- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07291479
Behavioral Assessment Method Index (BAM)
December 5, 2025 updated by: Jill Heathcock, Ohio State University
Development of Upper Extremity Behavioral Assessment Methods for Reach-and-grasp and Physical Rehabilitation.
The overall goal of this study is to develop and improve assessment methods for children with and without perinatal arterial ischemic stroke (PAS)/hemiparetic cerebral palsy (HCP).
The focus is on behaviors of the arms and hands and includes other domains of child development like fine motor, gross motor, language, cognition, and social-emotional skills.
This study involves 1) the use of data, including video recordings, from "I-ACQUIRE - Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation" (NCT03910075) and 2) a prospective longitudinal observational data collection with a typically developing cohort using a comprehensive assessment battery (play, fine motor, gross motor, language, cognition, and social emotional skills).
The current study is called the BAM Index.
No intervention or treatment is provided as part of the BAM Index.
The I-ACQUIRE study is an RCT that includes an intervention.
The BAM index study is a use of data from the I-ACQUIRE cohorts and a prospective observational study of a typically developing cohort (children without stroke or cerebral palsy) over time.
The results of this work will develop, test, refine, and validate a new methodology based on reach-and-grasp and other behaviors related to child development that will have profound and lasting impact on assessment and selection of treatment strategies for pediatric physical rehabilitation of children.
The use and reuse of video technology is also well-suited to remote or virtual assessment.
This proposal will add to our current knowledge by 1) yielding a psychometrically robust and alternative approach to measuring upper extremity function in children with stroke and/or hemiparetic cerebral palsy and 2) defining specific parameters about how to promote closer-to-normal upper extremity function in children with motor disability.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jill Heathcock, PhD
- Phone Number: (614) 292-2397
- Email: jill.heathcock@osumc.edu
Study Contact Backup
- Name: Petra Sternberg, PhD
- Phone Number: 614-572-5446
- Email: petra.sternberg@osumc.edu
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- Recruiting
- The Ohio State University
-
Contact:
- Jill Heathcock, PhD
- Phone Number: (614) 292-2397
- Email: jill.heathcock@osumc.edu
-
Contact:
- Petra Sternberg, PhD
- Phone Number: 614-572-5446
- Email: petra.sternberg@osumc.edu
-
Principal Investigator:
- Jill Heathcock, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Healthy, typically developing children, born at full-term.
Description
Inclusion Criteria:
- Between 8 and 36 months old at baseline
- Full Term Birth (37 to 41 weeks gestation)
- Healthy development (meeting age-appropriate milestones)
Exclusion Criteria:
- Diagnosed or suspected impairments (auditory, visual, cognitive or motor)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Typically developing infants
|
Prospective sample is typically developing.
No intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Behavioral Assessment Methods (BAM)
Time Frame: From enrollment to the last assessment (7 months).
|
Calculated based on reach- and grasp parameters with a variety of object explorations.
|
From enrollment to the last assessment (7 months).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
How the BAM index is related to fine motor, gross motor, cognition, and language skills across development for typical and atypical infants.
Time Frame: From enrollment to the last assessment (7 months).
|
Clinician and parent collected standardized measures.
|
From enrollment to the last assessment (7 months).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 7, 2023
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Study Registration Dates
First Submitted
December 5, 2025
First Submitted That Met QC Criteria
December 5, 2025
First Posted (Actual)
December 18, 2025
Study Record Updates
Last Update Posted (Actual)
December 18, 2025
Last Update Submitted That Met QC Criteria
December 5, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021H0419
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.